Inverness Medical Innovations has announced that its previously announced acquisition of BBI Holdings, a manufacture of non-invasive lateral flow tests, was successfully completed on February 12, 2008.
Subscribe to our email newsletter
The final purchase price consisted of $123.2 million cash and approximately 251,300 shares of Inverness common stock. In addition, existing options to purchase BBI stock have been assumed and have converted into options to purchase approximately 360,000 shares of Inverness common stock.